Label-Free Electrochemical Biosensor for Monitoring of Chloride Ion in an Animal Model of Alzhemier's Disease

A Self-Supporting Flexible Electrode for Tracking and Reversible Quantification of Mg2+ and Ca2+ in the Brains of Freely Behaving Animal

Monitoring dynamic neurochemical signals in the brain of free-moving animals remains great challenging in biocompatibility and direct implantation capability of current electrodes. Here we created a self-supporting polymer-based flexible microelectrode (rGPF) with sufficient bending stiffness for direct brain implantation without extra devices, but demonstrating low Young's modulus with remarkable biocompatibility and minimal position shifts. Meanwhile, screening by density functional theory (DFT) calculation, we designed and synthesized specific ligands targeting Mg2+ and Ca2+, and constructed Mg-E and Ca-E sensors with high selectivity, good reversibility, and fast response time, successfully monitoring Mg2+ and Ca2+ in vivo up to 90 days. Using this powerful tool, we discovered for the first time that, during the 4-aminopyridine-induced seizure in the live brain, extracellular Mg2+ inhibited Ca2+ influx. Moreover, the timing of initial changes in Mg2+ and Ca2+ levels during seizures aligned with neural pathways, which had not been previously reported.

Advances in Alzheimer's disease control approaches via carbon nanotubes

Global concern about Alzheimer's disease (AD) is justified by its increasingly younger onset and significant economic burden. AD leads to neurodegeneration and cognitive decline, ultimately resulting in loss of autonomy. Against this background, the field of biomedical research has seen a surge of interest in the potential of carbon-based nanomaterials, mainly due to their ease of degradation and high biocompatibility. Carbon nanotubes (CNTs) have been extensively studied in AD, including developing biosensors, drug delivery systems, and molecular imaging. Here, we introduced the biosafety and biodegradability of CNTs, with a particular focus on their uptake and degradation in brain tissue. The utilization of CNT in the context of AD therapy can facilitate the advancement of control approaches regimens and ensure the clinical safety of patients. This is achieved through the employment of these nanotubes as carriers for the delivery of drugs to the central nervous system (CNS), the detection of neurotransmitters such as acetylcholine (Ach) and monoamines, the development of biosensors and molecular imaging materials, the inhibition of Aβ formation and the detection of phosphorylated tau proteins, the promotion of CNS regeneration, and the modulation of ion-associated AD.

In vivo dynamic tracking of cerebral chloride regulation using molecularly tailored liquid/liquid interfacial ultramicro iontronics

Chloride ion, a pivotal cerebral anion involved in neuronal inhibition, is implicated in various neurodegenerative diseases. Conventional direct faradaic detection based on electron transfers at solid electrode/solution interfaces has been proven ineffective due to the electrochemically inactive nature of Cl-. Here, we present an approach involving molecularly tailored liquid/liquid interfacial ultramicro iontronics (L/L-UIs) supported at ultramicropipettes filled with organic gel containing lipophilic bis-thioureas ionophores, which represents the first application of amperometric methodology based on electrochemical facilitated ion transfers reactions at a soft L/L ultramicrointerface to achieve in vivo sensing of electrochemically inactive ions, and dynamically tracking cerebral Cl- in vivo. Furthermore, evidence of dynamic neuronal Cl- regulation via KCC2 modulated through GABAB receptors was provided, further substantiating GABAB receptor-mediated Cl--related neuronal inhibition. The proposed L/L-UIs have notable potential for in situ tracking of other crucial electrochemically inactive ions or ionized biomolecules in vivo, thereby facilitating the study of brain diseases and the diagnosis and treatment of related disorders.

Real-Time Tracking of Electrical Signals and an Accurate Quantification of Chemical Signals with Long-Term Stability in the Live Brain

The development of in vivo analytical tools and methods for recording electrical signals and accurately quantifying chemical signals is a key issue for a comprehensive understanding of brain events. The electrophysiological microelectrode was invented to monitor electrical signals in free-moving brains. On the other hand, electrochemical assays with excellent spatiotemporal resolution provide an effect way to monitor chemical signals in vivo. Unfortunately, the in vivo electrochemical biosensors still have three limitations. First, many biological species such as reactive oxygen species (ROS) and neurotransmitters demonstrate large overpotentials at conventional electrodes. Thus, it is hard to convert the chemical/electrochemical signals of these molecules into electric signals. Second, the interfacial properties of the recognition molecules assembled onto the electrode surfaces have a great influence on the transmission of electric charge through the interface and the stability of the modified recognition molecules. Meanwhile, the surface of biosensors implanted in the brain is easily absorbed by many proteins present in the brain, resulting in the loss of signals. Finally, activities in the brain including neuron discharges and electrophysiological signals may be affected by electrochemical measurements due to the application of extra potentials and/or currents.This Account presents a deep view of the fundamental design principles and solutions in response to the above challenges for developing in vivo biosensors with high performance while meeting the growing requirements, including high selectivity, long-time stability, and simultaneously monitoring electrical and chemical signals. We aim to highlight the basic criteria based on a double-recognition strategy for the selective biosensing of ROS, H₂S, and H_nS through the rational design of specific recognition molecules followed by electrochemical oxidation or reduction. Recent developments in designing functionalized surfaces through a systematic investigation of self-assembly with Au-S bonds, Au-Se bonds, and Au≡C bonds for facilitating electrochemical properties as well as improving the stability are summarized. More importantly, this Account highlights the novel methodologies for simultaneously monitoring electrical and chemical signals ascribed to the dynamic changes in K⁺, Na⁺, and Ca²⁺ and pH values in vivo. Additionally, SERS-based photophysiological microarray probes have been developed for quantitatively tracking chemical changes in the live brain together with recording electrophysiological signals.The design principles and novel strategies presented in this Account can be extended to the real-time tracking of electrical signals and the accurate quantification of more chemical signals such as amino acids, neurotransmitters, and proteins to understand the brain events. The final part also outlines potential future directions in constructing high-density microarrays, eventually enabling the large-scale dynamic recording of the chemical expression of multineuronal signals across the whole brain. There is still room to develop a multifiber microarray which can be coupled with photometric methods to record chemical signals both inside and outside neurons in the live brains of freely moving animals to understand physiological processes and screen drugs.

Dual-Ligand Near-Infrared Luminescent Lanthanide-Based Metal-Organic Framework Coupled with In Vivo Microdialysis for Highly Sensitive Ratiometric Detection of Zn2+ in a Mouse Model of Alzheimer's Disease

Zinc, which is the second most abundant trace element in the human central nervous system, is closely associated with Alzheimer's disease (AD). However, attempts to develop highly sensitive and selective sensing systems for Zn²⁺ in the brain have not been successful. Here, we used a one-step solvothermal method to design and prepare a metal-organic framework (MOF) containing the dual ligands, terephthalic acid (H₂BDC) and 2,2':6',2″-terpyridine (TPY), with Eu³⁺ as a metal node. This MOF is denoted as Eu-MOF/BDC-TPY. Adjustment of the size and morphology of Eu-MOF/BDC-TPY allowed the dual ligands to produce multiple luminescence peaks, which could be interpreted via ratiometric fluorescence to detect Zn²⁺ using the ratio of Eu³⁺-based emission, as the internal reference, and ligand-based emission, as the indicator. Thus, Eu-MOF/BDC-TPY not only displayed higher selectivity than other metal cations but also offered a highly accurate, sensitive, wide linear, color change-based technique for detecting Zn²⁺ at concentrations ranging from 1 nM to 2 μM, with a low limit of detection (0.08 nM). Moreover, Eu-MOF/BDC-TPY maintained structural stability and displayed a fluorescence intensity of at least 95.4% following storage in water for 6 months. More importantly, Eu-MOF/BDC-TPY sensed the presence of Zn²⁺ markedly rapidly (within 5 s), which was very useful in practical application. Furthermore, the results of our ratiometric luminescent method-based analysis of Zn²⁺ in AD mouse brains were consistent with those obtained using inductively coupled plasma mass spectrometry.

Fluorescent Probes Design Strategies for Imaging Mitochondria and Lysosomes

Modern cellular biology faces several major obstacles, such as the determination of the concentration of active sites corresponding to chemical substances. In recent years, the popular small-molecule fluorescent probes have completely changed the understanding of cellular biology through their high sensitivity toward specific substances in various organisms. Mitochondria and lysosomes are significant organelles in various organisms, and their interaction is closely related to the development of various diseases. The investigation of their structure and function has gathered tremendous attention from biologists. The advanced nanoscopic technologies have replaced the diffraction-limited conventional imaging techniques and have been developed to explore the unknown aspects of mitochondria and lysosomes with a sub-diffraction resolution. Recent progress in this field has yielded several excellent mitochondria- and lysosome-targeted fluorescent probes, some of which have demonstrated significant biological applications. Herein, we review studies that have been carried out to date and suggest future research directions that will harness the considerable potential of mitochondria- and lysosome-targeted fluorescent probes.

Novel Self-Calibrating Amperometric and Ratiometric Electrochemical Nanotip Microsensor for pH Measurement in Rat Brain

Brain pH has been proven to be a key factor in maintaining normal brain function. The relationship between local pH fluctuation and brain disease has not been extensively studied due to lack of the accurate in situ analysis technology. Herein, we have for the first time proposed a voltammetric pH sensor by measuring the ratio of current signals instead of the previously reported potential based on the Nernst equation. Single-walled carbon nanotubes (CNT) were first self-assembled on the electrode surface of a carbon-fiber nanotip electrode (CFNE). Then, poly-o-phenylenediamine (PoPD) molecules were deposited as pH-responsive molecules through in situ electrochemical polymerization. The compact CFNE/CNT/PoPD exhibited a good redox process with the on-off-on ratiometric electrochemical response to pH ranging from 4.5 to 8.2, providing self-correction for in situ pH detection. Thus, the proposed sensor enabled the accurate measurement of pH with excellent selectivity even in the presence of proteins or electroactive species. In addition, the sensor showed high repeatability, reproducibility, and reversibility in measuring pH and even demonstrated good stability when it was exposed to air for 5 months. Finally, we successfully detected the fluctuation of pH in rat brains with cerebral ischemia and rat whole blood. Overall, this research not only provides a good tool for the detection of rat brain pH but also provides a new strategy for further designing nanosensors for intracellular or subcellular pH.

A ratiometric electrochemical microsensor for monitoring chloride ions in vivo

Chloride ion (Cl^-), the most common anion in animal brain, has been verified to play a vital role in maintaining normal physiological processes. Thus, development of a reliable platform to determine Cl^- is of great significance for brain research involving Cl^-. In this work, a ratiometric electrochemical microsensor (REM) for the in vivo measurement of cerebral Cl^- was designed. To prepare REM, uniform Ag nanoparticles (Ag NPs) with nano-level sizes were synthesized via an adsorption-reduction process, which served as selective recognition elements for Cl^- determination, while methylene blue (MB) was absorbed and acted as an inner reference unit to avoid the environmental interference of complicated brain systems. As a result, this developed REM exhibited high sensitivity and selectivity, as well as good stability, reproducibility and anti-biofouling. This reliable approach was established to monitor Cl^- in mouse brain.

Reversible Structural Transformation of CuI-TbIII Heterometallic MOFs with Highly Efficient Detection Capability toward Penicillin

A Cu^I-Tb^III heterometallic MOF, namely 1·DMF, was obtained via a coordination assembly process of isonicotinic acid with Cu^I and Tb^III. 1·DMF can be switched to 1·MeOH in methanol with a luminescent emission response. Meanwhile, 1·MeOH exhibits a reversible single-crystal transformation to 1·DMF after immersion in DMF. Both MOFs have superior physicochemical stability. The 1·DMF-based biosensor has a remarkable sensing performance toward penicillin.

A label-free ratiometric immunoassay using bioinspired nanochannels and a smart modified electrode

Labeling with redox reporter is often required in developing electrochemical bioassay for most proteins or nucleic acid biomarkers. Herein, a label-free ratiometric immunosensing platform is firstly developed by integrating the antibody-conjugated nanochannels with a smart modified electrode. The electrode modifier is the composite of C₆₀, tetraoctylammonium bromide (TOA⁺) and Prussian blue (PB). Cyclic voltammograms of the ultimate C₆₀-TOA⁺/PB modified electrode exhibited two pairs of peaks at 0.15 V and -0.13 V, ascribing to the redox of PB and C₆₀, respectively. With the addition of K₃[Fe(CN)₆] in the electrolyte solution, the peaks of PB decreased due to the adsorption of [Fe(CN)₆]^3- while the peaks of C₆₀ increased because of the formation of the ternary complex (TC) C₆₀-TOA⁺-[Fe(CN)₆]^3-. As a result, the peak current ratio I_PB/I_TC decreased gradually with the increment of the concentration of [Fe(CN)₆]^3-. For the nanochannels-based immunosensing platform, the steric hindrance of the bioconjugated nanochannels varied with the loading amount of the target CA125, and thus [Fe(CN)₆]^3- passing through the channels was quantitatively affected. And the higher CA125 level was, the less [Fe(CN)₆]^3- concentration was. And thus, the ratio I_PB/I_TC monitored at the C₆₀-TOA⁺/PB modified electrode increased with the increase of the concentration of CA125. The ratiometric immunoassay featured a linear calibration range from 1.0 U mL^-1 to 100 U mL^-1 with a low detection limit of 0.86 U mL^-1. In addition, the ratiometric immunosensing platform demonstrated good specificity and stability as well as acceptable accuracy in overcoming the effect of electrode passivation which was an inherent problem of electroanalysis.

Facile Electrochemical Microbiosensor Based on In Situ Self-Assembly of Ag Nanoparticles Coated on Ti3C2Tx for In Vivo Measurements of Chloride Ions in the PD Mouse Brain

Chloride ion (Cl^-), one of the most important anions in the brain, has been confirmed to participate in the pathological process of Parkinson's disease (PD). As such, the development of a reliable method for in vivo measurements of Cl^- is extremely appealing, especially for understanding the pathogenesis of PD. We herein designed a facile electrochemical microbiosensor (ECMB), based on in situ self-assembly of Ag nanoparticles (Ag NPs) coated on Ti₃C₂T_x. The uniform nanosized Ag NPs were reduced by Ti₃C₂T_x by a simple dipping process, endowing the ECMB with excellent specificity toward Cl^- detection and remarkably reproducible preparation process. Meanwhile, electro-oxidized graphene oxide was introduced as an inner reference, thus avoiding the environmental interference of the complicated brain systems to increase the determination accuracy. An extensive in vitro study revealed that the proposed ECMB would be a robust candidate for real-time monitoring of Cl^- in the PD mouse brain with high selectivity, accuracy, and reproducibility. Moreover, the availability and reliability toward in vivo Cl^- monitoring of the designed ECMB were well confirmed by comparing with the standard Volhard's method. Finally, by virtue of the successful employment of the developed detecting platform in the in vivo measurement of Cl^- in the PD mouse brain, systematic analysis and comparison of the average levels of Cl^- in the three regions including cortex, striatum, and hippocampus of brains from normal and PD model mice have been achieved.

Brain neurochemical monitoring

Brain neurochemical monitoring aims to provide continuous and accurate measurements of brain biomarkers. It has enabled significant advances in neuroscience for application in clinical diagnostics, treatment, and prevention of brain diseases. Microfabricated electrochemical and optical spectroscopy sensing technologies have been developed for precise monitoring of brain neurochemicals. Here, a comprehensive review on the progress of sensing technologies developed for brain neurochemical monitoring is presented. The review provides a summary of the widely measured clinically relevant neurochemicals and commonly adopted recognition technologies. Recent advances in sampling, electrochemistry, and optical spectroscopy for brain neurochemical monitoring are highlighted and their application are discussed. Existing gaps in current technologies and future directions to design industry standard brain neurochemical sensing devices for clinical applications are addressed.

"Turn-on" ratiometric electrochemical detection of H2O2 in one drop of whole blood sample via a novel microelectrode sensor

Oxidative stress plays an important role in the pathogenesis of many diseases, while the exact mechanism that hydrogen peroxide (H₂O₂) as one of the most abundant reactive oxygen species (ROS) exerts its influence on oxidative stress remains unclear. We developed a novel turn-on ratiometric electrochemical sensor for the detection of H₂O₂ in blood samples. The electrochemical probe 5-(1,2-dithiolan-3-yl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pent-anamide (BA) was designed and synthesized for the selective detection of H₂O₂ via a one-step amide reaction. Meanwhile, Nile Blue A (NB) was optimized as an internal reference molecule, thus enabling accurate quantification of H₂O₂ in a complex environment. BA and NB were then co-assembled onto a carbon fiber microelectrode (CFME) coated with Au cones. The oxidation peak current ratio between BA and NB demonstrated good linearity with the logarithm of the H₂O₂ concentration values ranging from 0.5 μM to 400 μM with a low detection limit of 0.02 μM. The developed sensor showed remarkable selectivity against potential interferences in whole blood samples, especially for ascorbic acid, uric acid, and dopamine. In combination with the unique characteristics of CFME, such as a small size and good biocompatibility, the microsensor was used for rapid analysis of one drop of whole blood sample. This sensor not only creates a new platform for the detection of H₂O₂ in whole blood samples, but also provides a new design strategy of other ROS analysis for early diagnosis of ROS-related diseases, drug discovery processes, and pathological mechanisms.

Simplified synthesis of silver nanoparticles on graphene oxide and their applications in electrocatalysis

In this work the possibility of synthesizing in situ silver nanoparticles (AgNPs) on graphene oxide (GO) surfaces without commonly used additional reducing or alkalizing agents or increased temperature was investigated. Using diverse microscopic (atomic force microscopy, transmission electron microscopy) and spectroscopic methods, it was proved that very small AgNPs were formed on GO by simple incubation for 2 h in a mixture of GO dispersion and AgNO₃. The prepared nanomaterial (GO_Ag) was also assessed using electrochemical methods, and it exhibited electrochemical behavior similar to the GO_Ag nanomaterial prepared with a help of citric acid as a reducing agent. Furthermore, it was found that (i) the electrochemical reduction of the GO_Ag on the electrode surface decreased the voltammetric response even though this step increased the surface conductivity and (ii) GO_Ag can be employed for the sensing of chlorides with a detection limit of 79 μM and a linear range of up to 10 mM. It could also provide an electrochemical response toward the chloroacetanilide herbicide metazachlor. Hence, the reducing capabilities of GO were proved to be applicable for in situ synthesis of metal nanoparticles with the highest possible simplification, and the as-prepared nanomaterials could be employed for fabrication of different electrochemical sensors.

Single-molecule biosensors: Recent advances and applications

Single-molecule biosensors serve the unmet need for real time detection of individual biological molecules in the molecular crowd with high specificity and accuracy, uncovering unique properties of individual molecules which are hidden when measured using ensemble averaging methods. Measuring a signal generated by an individual molecule or its interaction with biological partners is not only crucial for early diagnosis of various diseases such as cancer and to follow medical treatments but also offers a great potential for future point-of-care devices and personalized medicine. This review summarizes and discusses recent advances in nanosensors for both in vitro and in vivo detection of biological molecules offering single-molecule sensitivity. In the first part, we focus on label-free platforms, including electrochemical, plasmonic, SERS-based and spectroelectrochemical biosensors. We review fluorescent single-molecule biosensors in the second part, highlighting nanoparticle-amplified assays, digital platforms and the utilization of CRISPR technology. We finally discuss recent advances in the emerging nanosensor technology of important biological species as well as future perspectives of these sensors.

Real-time monitoring of peroxynitrite (ONOO−) in the rat brain by developing a ratiometric electrochemical biosensor

As a reactive oxygen species (ROS), peroxynitrite (ONOO⁻) generated by nitric oxide (NO) and superoxide anion (O₂˙⁻) plays important roles in physiological and pathological processes in the brain.

Sensitive detection of MCF-7 human breast cancer cells by using a novel DNA-labeled sandwich electrochemical biosensor

The simple, rapid, sensitive, and specific detection of cancer cells plays a pivotal role in the diagnosis and prognosis of cancer. We developed a novel DNA-labeled sandwich electrochemical biosensor based on a glassy carbon electrode modified with 3D graphene and a hybrid of Au nanocages (Au NCs)/amino-functionalized multiwalled carbon nanotubes (MWCNT-NH₂) for label-free and selective detection of MCF-7 breast cancer cells via differential pulse voltammetry. The layer-by-layer assembly and cell-detection performance of the Au NCs/MWCNTs-NH₂-based biosensor were investigated using scanning electron microscopy and electrochemical methods including cyclic voltammetry and electrochemical impedance spectroscopy. Owing to the advantages of DNA-labeled antibodies and a nanomaterial-based signal amplification strategy, the fabricated cytosensor exhibited high specificity and sensitivity when detecting MCF-7 cells in the range of 1.0 × 10² to 1.0 × 10⁶ cells mL^-1 with a low detection limit of 80 cells mL^-1 (3σ/slope). Furthermore, the biosensor exhibited high selectivity when detecting MCF-7 cells and showed considerable potential for practical applications. The proposed DNA-labeled sandwich electrochemical biosensor provides a stable, sensitive approach to detecting cancer cells and is promising in terms of potential applications to cancer diagnosis.

Designing Recognition Molecules and Tailoring Functional Surfaces for In Vivo Monitoring of Small Molecules in the Brain

The in vivo analysis of chemical signals in brain extracellular fluid (ECF) using implanted electrochemical biosensors is a vital way to study brain functions and brain activity mapping. This approach offers excellent spatial (10-200 μm) and temporal (approximately second) resolution and the major advantage of long-term stability. By implantation of a microelectrode in a specific brain region, changes in the concentration of a variety of ECF chemical species can be monitored through applying a suitable electrical signal and, typically, recording the resulting Faradaic current. However, the high performance requirements for in vivo biosensors greatly limit our understanding of the roles that biomolecules play in the brain. Since a large number of biological species, including reactive oxygen species (ROS), metal ions, amino acids, and proteins, coexist in the brain and interact with each other, developing in vivo biosensors with high selectivity is a great challenge. Meanwhile, it is difficult to quantitatively determine target molecules in the brain because of the variation in the distinct environments for monitoring biomolecules in vitro and in vivo. Thus, there are large errors in the quantification of concentrations in the brain using calibration curves obtained in artificial cerebrospinal fluid (aCSF). More importantly, to gain a full understanding of the physiological and pathological processes in the brain, the development of novel approaches for the simultaneous determination of multiple species in vivo is urgently needed. This Account provides insight into the basic design principles and criteria required to convert chemical/electrochemical reactions into electric signals, while satisfying the increasing requirements, including high selectivity, sensitivity, and accuracy, for the in vivo analysis of biomolecules in the brain. Recent developments in designing various functional surfaces, such as self-assembled monolayers, gold nanostructures, and nanostructured semiconductors for facilitating electron transfer from specific enzymes, including superoxide dismutase (SOD), and further application to an O₂^•- biosensor are summarized. This Account also aims to highlight the design principles for the selective biosensing of Cu²⁺ and pH in the brain through the rational design and synthesis of specific recognition molecules. Additionally, electrochemical ratiometric biosensors with current signal output have been constructed to correct the effect of distinct environments in a timely manner, thus greatly improving the accuracy of the determination of Cu²⁺ in the live brain. This method of using a built-in element has been extended to biosensors with the potential signal output for in vivo pH analysis. More importantly, the new concept of both current and potential signal outputs provides an avenue to simultaneously determine dual species in the brain. The extension of the design principles and developed strategy demonstrated in this Account to other biomolecules, which may be closely correlated to the biological processes of brain events, is promising. The final section of this Account outlines potential future directions in tailoring functional surfaces and designing recognition molecules based on recent advances in molecular science, nanoscience and nanotechnology, and biological chemistry for the design of advanced devices with multiple target species to map the molecular imaging of the brain. There are still opportunities to engineer surfaces that improve on this approach by constructing implantable, multifunctional nanodevices that promise to combine the benefits of multiple sensing and therapeutic modules.